Wednesday, January 21, 2026 11:37:20 AM
georgie18
Member Level
Re: georgie18 post# 712184
Wednesday, January 21, 2026 9:59:29 AM
Post#
712208
of 712246
MRNA...$45.94...🥳...Off my Cup N Handle Alert at $34.78...
georgie18
Member Level
Re: georgie18 post# 14120
Wednesday, January 21, 2026 8:39:44 AM
Post#
14124
of 14124
MRNA...$43.28...🥳...Off my Cup N Handle Alert at $34.78...
georgie18
Member Level
Re: georgie18 post# 711425
Friday, January 16, 2026 10:20:42 AM
Post#
711891
of 712184
MRNA...$41.60...🥳...Off my Cup N Handle at $34.78...
georgie18
Member Level
Re: georgie18 post# 14113
Tuesday, January 13, 2026 1:41:21 PM
Post#
14114
of 14119
MRNA...$39.20...🥳...Cup N Handle Breakout...
georgie18
Member Level
Re: georgie18 post# 710826
Tuesday, January 13, 2026 12:41:58 PM
Post#
711413
of 711413
MRNA...$38.55...🥳...Cup N Handle Alert at $34.78...
georgie18
Member Level
Re: None
Wednesday, January 07, 2026 9:09:11 AM
Post#
14111
of 14112
MRNA...$34.78...🥳... https://schrts.co/NpWHXNfT ...Cup N Handle Breakout setting up here...Will enter on the Break/Hold of $36...
Recent MRNA News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 09:24:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 09:21:25 PM
- Moderna agrees up to $2.25 billion settlement in COVID vaccine patent dispute • IH Market News • 03/04/2026 11:24:49 AM
- Moderna Resolves Global Patent Litigation with Arbutus/Genevant • ACCESS Newswire • 03/03/2026 09:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 09:14:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 09:10:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 09:04:51 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/02/2026 02:56:47 PM
- European Medicines Agency's Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Marketing Authorization of mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influenza and COVID-19 • ACCESS Newswire • 02/27/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/25/2026 09:49:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/23/2026 03:26:22 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/20/2026 09:03:07 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/20/2026 09:02:04 PM
- Moderna to Present at Upcoming Conferences in March 2026 • ACCESS Newswire • 02/19/2026 12:00:00 PM
- Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine Submission • ACCESS Newswire • 02/18/2026 12:00:00 PM
- Moderna Receives European Commission Marketing Authorization for COVID-19 Vaccine mNEXSPIKE • ACCESS Newswire • 02/17/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2026 09:41:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2026 09:33:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2026 12:02:14 PM
- Moderna Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Updates • ACCESS Newswire • 02/13/2026 12:00:00 PM
- Moderna Receives Refusal-to-File Letter from the U.S. Food and Drug Administration for Its Investigational Seasonal Influenza Vaccine, mRNA-1010 • ACCESS Newswire • 02/10/2026 11:00:00 PM
- Moderna to Enter into Long-Term Strategic Agreement with the Government of Mexico • ACCESS Newswire • 02/10/2026 12:00:00 PM
- The $71 Billion Cancer Shift: Why The FDA Is Speeding Up • GlobeNewswire Inc. • 02/05/2026 02:26:03 PM
- Defiance Launches MRNX: The First Daily 2X Long ETF for Moderna, Inc. • GlobeNewswire Inc. • 02/04/2026 02:15:00 PM
- Dr. David Berman to Join Moderna as Chief Development Officer • ACCESS Newswire • 01/30/2026 12:30:00 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
